Psychological Medicine · 20 Nov 2026
Effects of specialised and centralised versus generalised and decentralised outpatient treatment for progressed bipolar disorder: Results from the CAG Bipolar randomised controlled trial
Lars Vedel Kessingh-index 100, Natacha Blauenfeldt Kyster, Ellen Margrethe Christensen, Sarah Krarup Larsen, Birte Smidt, Ulla Knorr, Louise Behrend Rasmussen, Henrik Nørbak-Emig, Darius Mardosas, Jens Otto Drachmann Bukh, Gudmunda Sirry Arnardottir, Maj Vinberg, Ida Hageman, Asbjørn Risom, Esben Budtz-Jørgensen, Maria Faurholt-Jepsen, in cooperation with the CAG Bipolar Study Group
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Background Clinical Academic Group (CAG) is a new organization of treatment bringing together clinical services, research, education, and training to provide evidence-based care. We aimed, for the first time, to investigate whether specialized and centralized outpatient treatment (CAG Bipolar) versus decentralized community-based treatment improves patient outcomes and satisfaction with care in patients with progressed bipolar disorder. Methods A pragmatic randomized controlled trial was undertaken with individual randomization to 1) specialized and centralized outpatient treatment in CAG Bipolar or 2) generalized and decentralized community-based outpatient treatment. The 12-month outcomes were 1) cumulated number and duration of psychiatric hospitalizations, and 2) psychotropic medication, coercion, self-rated depressive and manic symptoms, quality of life, perceived stress, and satisfaction with care. Results There was no difference among 1,134 included patients in cumulated number (RR: 0.94 (95% CI: 0.74–1.14), p = 0.6) or duration (0.16 days, (95% CI: −4.10-4.42; p = 0.9) of psychiatric hospitalizations. Lithium (RR: 1.19 (95% CI: 1.05–1.33) and antipsychotics (RR: 1.09 (95% CI: 1.01–1.17), specifically quetiapine (RR: 1.17 (95% CI: 1.03–1.30), were prescribed more in the CAG Bipolar group, and CAG Bipolar patients were overall more satisfied with care including the skills of the professionals, information and the efficacy of the service. There was no difference in coercion, self-rated depressive or manic symptoms, quality of life or perceived stress. Conclusions Specialized and centralized outpatient treatment for progressed bipolar disorder does not result in improvement in robust outcome measures such as hospitalization and coercion, but in the use of psychotropic medication concordant with international guidelines, and increased satisfaction with care.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Lars Vedel Kessing has the highest h-index among the authors (100).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (30)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 10 more references
A free account opens the rest of the citing papers and references on every paper’s page.